Harmony Biosciences Holdings (HRMY)
Number of days of payables
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | 29.24 | 36.93 | 16.24 | 23.29 | 19.05 | 47.48 | 45.25 | 44.57 | 71.25 | 25.17 | 35.24 | 31.31 | 205.76 | 45.80 | 85.61 | |
Number of days of payables | days | 12.48 | 9.88 | 22.48 | 15.67 | 19.16 | 7.69 | 8.07 | 8.19 | 5.12 | 14.50 | 10.36 | 11.66 | 1.77 | 7.97 | 4.26 |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 29.24
= 12.48
The number of days of payables for Harmony Biosciences Holdings has shown some fluctuations over the period from June 30, 2021, to December 31, 2024. This ratio measures the average number of days it takes for the company to pay its suppliers after a purchase has been made.
We observe that the number of days of payables ranged from a low of 1.77 days on December 31, 2021, which indicates a very efficient payment cycle, to a high of 22.48 days on June 30, 2024. Generally, a lower number of days of payables suggests that the company is paying its suppliers more quickly, which can be beneficial for maintaining positive supplier relationships. On the other hand, a higher number of days of payables may indicate potential liquidity or cash flow concerns.
It is notable that there were significant increases in the number of days of payables observed towards the end of the period, particularly on December 31, 2023, and June 30, 2024, which could be a sign of changing payment practices or operational challenges. Further examination of the company's financial health and cash flow management is recommended to better understand the reasons behind these fluctuations in the number of days of payables.
Peer comparison
Dec 31, 2024